Highlights
Social Forum >> Forum Thread
Last Price Today's Change   Day's Range   Trading Volume
2.32   +0.02 (0.87%)  2.28 - 2.36  102,600
2,013 comment(s). Last comment by hahasong at Sep 17, 2020 9:34 AM
Like
 5 people like this.
 
 Post Reply   Back  
Page < 32 33 34 35 36 37 38 39 40 41

ShareNews
42 posts

Posted by ShareNews > Aug 26, 2020 10:18 AM | Report Abuse

wah...this company rich of CASH of 104mils...almost 74sen per share with low borrowings. BUY BUY BUY


Keyman188
2243 posts

Posted by Keyman188 > Aug 26, 2020 10:22 AM | Report Abuse

As per 2019 annual report

Cash & Cash equivalent : RM 90,083,000

Less Loan & Borrowings : RM 28,831,000 + RM 9,915,000

So net cash now : RM 51,337,000


** Don't simply tembak


ShareNews
42 posts

Posted by ShareNews > Aug 26, 2020 10:26 AM | Report Abuse

you just c the latest QR lo...


Klse0314
2 posts

Posted by Klse0314 > Aug 26, 2020 11:10 AM | Report Abuse

good counter to invest no matter long term or short term, long term invest to earn dividend compared bank interest which lower now. short term invest if vaccine is available, investor favor hearth care counter


chshzhd
1448 posts

Posted by chshzhd > Aug 26, 2020 11:46 AM | Report Abuse

no problem .. just keep ..


Benlee88888
74 posts

Posted by Benlee88888 > Aug 26, 2020 1:54 PM | Report Abuse

Long term shares. No problem
Slowly slowly up, I like it.


chshzhd
1448 posts

Posted by chshzhd > Aug 27, 2020 12:31 AM | Report Abuse

cheapest pharma counter with 3% div (highest among others)


mayongzheng
399 posts

Posted by mayongzheng > Sep 1, 2020 8:54 PM | Report Abuse

https://youtu.be/eIgQAOLapj8


cpng
1575 posts

Posted by cpng > Sep 3, 2020 10:02 AM | Report Abuse

永信藥品聚焦重症感染藥物
今年營運續增6%

永信藥品聚焦發展重症感染藥物,深化自原料藥至製劑垂直整合技術能力;今年因應疫情衝擊拉高原料庫存,原料成本均上揚,全年業績仍可望拚6%成長,維持穩定成長趨勢。

永信藥品今年由於疫情關係,各國對於抗疫物資的出口已相對保守,原物料供應鏈不若以往寬鬆,為確保生產線供貨穩定,避免來自中國大陸的料缺貨,去年底已陸續將原料存量拉高35%,目前外銷市場及內銷市場約2比8,每年成長6%的目標不變,各個品項成長動能均衡。

永信為全球少數擁有生物醱酵、化學合成技術以及藥品處方快篩技術綜合型藥廠。

近年來,由於抗生素的廣泛使用而產生抗藥性細菌,對病患健康產生重大威脅。

過去由於注射型抗黴菌藥物藥價昂貴、與臨床使用上的安全性問題,限制了病患的用藥時機與療程。

永信針對感染性疾病,持續深耕發展抗感染藥物,除了早期開發的廣效型抗生素藥物、中期發展預防性黴菌感染與抗病毒藥物,近期更朝向需求日增的重症感染領域,目前已經成功開發3項產品。

其中與台微體攜手合作,掌握特殊奈米化微脂體劑型的關鍵製程,已成功量產Amphotericin B (微脂體製劑),目前正配合進行歐、美、中等大型市場的查登作業。


cpng
1575 posts

Posted by cpng > Sep 3, 2020 2:15 PM | Report Abuse

Taiwanese new special medicine Silmitasertib (CX-4945) cured covid 19 in 5 days time.

http://www.senhwabiosciences.com/tw/new?cls=1491881153&guid=1599104946


Deskent
82 posts

Posted by Deskent > Sep 11, 2020 10:44 AM | Report Abuse

may I know dividend 8sen when will announce?


chesslim
658 posts

Posted by chesslim > Sep 11, 2020 5:26 PM | Report Abuse

Dividen 8sen already bank in to a/c at Aug. 25. 2020


hahasong
182 posts

Posted by hahasong > Sep 17, 2020 9:34 AM | Report Abuse

United States vaccine failed!

The glove unit ESCERAM 0100 is about to fly!

 Post Reply   Back  
Page < 32 33 34 35 36 37 38 39 40 41
APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards
 
 

525  363  569  632 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 MTRONIC 0.085+0.005 
 ASB 0.17-0.02 
 MNC 0.045-0.005 
 HLT 1.67+0.14 
 KANGER 0.235-0.025 
 MTOUCHE 0.065-0.005 
 VSOLAR 0.040.00 
 CAREPLS 3.15+0.33 
 MMAG-WB 0.13-0.04 
 TOPGLOV 8.55+0.53 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Stock selection criteria - Koon Yew Yin Koon Yew Yin's Blog
2. Technical View - Top Glove Corporation Bhd Rakuten Trade Research Reports
3. 'THE GREATER FOOL THEORY By Dr Neoh Soon Kean (Excerpts from STOCK MARKET INVESTMENT), Calvin Tan comments THE INVESTMENT APPROACH OF CALVIN TAN
4. TOPGLOVE: Employee Provident Fund (EPF) is back with Top Glove Van Gogh of Financial
5. Investor lodge complaint with SC against Macquarie downgrade on TOP GLOVE gloveharicut
6. TOP GLOVE is buying back own share. Why Director dispose share? LIM CHEONG GUAN should hold the share for a year. gloveharicut
7. Will Shareholders benefit when Top Glove spend Rm 310 million on share buyback? Koon Yew Yin Koon Yew Yin's Blog
8. [Humbled Investor] MFCB: Low Risk High Return? What is the Target Price? HumbledInvestor
PARTNERS & BROKERS